Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Agilent Wins SEAL Award for Innovative Products that Help Customers Achieve Their Sustainability Goalshttps://www.cyansecurity.com/:
Agilent Wins SEAL Award for Innovative Products that Help Customers Achieve Their Sustainability Goals


Agilent Technologies Inc. (NYSE: A) today received a SEAL Business Sustainability Award for producing products and technology that are helping analytical and clinical labs reduce their carbon

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Financial year 2022/23: Sonova delivers solid results 
and preserves profit growth
Financial year 2022/23: Sonova delivers solid results  and preserves profit growth
Financial year 2022/23: Sonova delivers solid results  and preserves profit growth
Inogen to Present at 43rd Annual William Blair Growth Stock Conference
Inogen to Present at 43rd Annual William Blair Growth Stock Conference


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that management will participate in the William

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend


Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company’s 2023 annual stockholders’ meeting. New to the Board is Eileen McCarthy, Senior Vice President of

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
EQS-News: ​​​​​​​Reorganization in the Executive Board of Eckert & Ziegler
EQS-News: ​​​​​​​Reorganization in the Executive Board of Eckert & Ziegler
EQS-News: ​​​​​​​Reorganization in the Executive Board of Eckert & Ziegler
EQS-News: Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate
EQS-News: Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate
EQS-News: Vita 34 Starts Recruitment for Clinical Trial with CAR-T Drug Candidate
Humana to Partner with Two National Durable Medical Equipment Organizations
Humana to Partner with Two National Durable Medical Equipment Organizations


Leading health and well-being company Humana Inc. (NYSE: HUM) announced today that it has reached agreement with two national organizations to provide Durable Medical Equipment (DME) services to

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
EQS-News: Eckert & Ziegler with Strong Sales Growth in the First Quarter of 2023
EQS-News: Eckert & Ziegler with Strong Sales Growth in the First Quarter of 2023
EQS-News: Eckert & Ziegler with Strong Sales Growth in the First Quarter of 2023
Dexcom Showcases Accuracy, Reliability and Ease of Use of Its Dexcom G6 CGM System at the 66th Annual Meeting of the Japan Diabetes Society
Dexcom Showcases Accuracy, Reliability and Ease of Use of Its Dexcom G6 CGM System at the 66th Annual Meeting of the Japan Diabetes Society


DexCom, Inc. (NASDAQ: DXCM), a global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, will showcase the accuracy, reliability and ease of use of its Dexcom G6 CGM

Chemed Corporation to Present at the 2023 RBC Global Healthcare Conference
Chemed Corporation to Present at the 2023 RBC Global Healthcare Conference


Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 17, 2023, at approximately 2:35 p.m. (ET)

Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug Development and Improve Patient Outcomes
Simulations Plus Launches New Integrated Pulmonary Software and Services Package to Streamline Drug Development and Improve Patient Outcomes


Simulations Plus, Inc. (Nasdaq: SLP), a leading provider of modeling and simulation software and services for pharmaceutical safety and efficacy, today announced the release of a new integrated

The Vanguard Group, Inc.: Mediclinic International plc
The Vanguard Group, Inc.: Mediclinic International plc
The Vanguard Group, Inc.: Mediclinic International plc
Premier, Inc. Evaluating Strategic Alternatives
Premier, Inc. Evaluating Strategic Alternatives


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today announced that its Board of Directors is evaluating potential strategic alternatives to enhance value

Owens & Minor to Present at the BofA Securities 2023 Health Care Conference on Tuesday, May 9, 2023
Owens & Minor to Present at the BofA Securities 2023 Health Care Conference on Tuesday, May 9, 2023


Owens & Minor, Inc. (NYSE: OMI), a global healthcare solutions company that incorporates product manufacturing, distribution support and innovative technology services, announced today that Ed

Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
Form 8.3 - The Vanguard Group, Inc.: Mediclinic International plc
EQS-News: Eckert & Ziegler: Recognized Australian Endocrine & Hypertension Center Joins International Groups with a Clinical Trial of PentixaPharm’s Primary Aldosteronism Lead Candidate
EQS-News: Eckert & Ziegler: Recognized Australian Endocrine & Hypertension Center Joins International Groups with a Clinical Trial of PentixaPharm’s Primary Aldosteronism Lead Candidate
EQS-News: Eckert & Ziegler: Recognized Australian Endocrine & Hypertension Center Joins International Groups with a Clinical Trial of PentixaPharm’s Primary Aldosteronism Lead Candidate
Owens & Minor Reports First Quarter 2023 Financial Results
Owens & Minor Reports First Quarter 2023 Financial Results


Owens & Minor, Inc. (NYSE: OMI) today reported financial results for the first quarter ended March 31, 2023.



Key Highlights:




  • Consolidated revenue of $2.5 billion in the first quarter


  • Net

Inogen Announces First Quarter 2023 Financial Results
Inogen Announces First Quarter 2023 Financial Results


Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced financial results for the quarter ended March 31

Acadia Healthcare to Participate in BofA Securities Healthcare Conference
Acadia Healthcare to Participate in BofA Securities Healthcare Conference


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will participate in the BofA Securities 2023 Healthcare Conference, May 9-11, 2023, in Las Vegas, Nevada.



In

Humana and Longevity Health Partner to Expand Access to Special Needs Plans for Medicare Beneficiaries
Humana and Longevity Health Partner to Expand Access to Special Needs Plans for Medicare Beneficiaries


Longevity Health Plan and Humana Inc. (NYSE: HUM) today announced a new partnership to expand special needs health plan offerings that support the unique requirements of Medicare-eligible

Agilent Announces Solutions Innovation Research Award to Dr. Jiangbin Ye
Agilent Announces Solutions Innovation Research Award to Dr. Jiangbin Ye


Agilent Technologies Inc. (NYSE: A) announced today that Dr. Jiangbin Ye has received an Agilent Solutions Innovation Research Award (SIRA). The award supports drug discovery and development